Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll-like receptor 2-mediated cell-penetrating peptide

STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation

(2012) Hazel Tye et al.   CANCER CELL

siRNA Delivery: From Lipids to Cell-penetrating Peptides and Their Mimics

(2012) Matt Gooding et al.   Chemical Biology & Drug Design

Cell-penetrating Peptides as a Novel Transdermal Drug Delivery System

(2012) Saman A. Nasrollahi et al.   Chemical Biology & Drug Design

Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice

(2012) Heng Lin et al.   HEPATOLOGY

Promiscuous Binding of Invariant Chain-Derived CLIP Peptide to Distinct HLA-I Molecules Revealed in Leukemic Cells

(2012) Marvin M. van Luijn et al.   PLoS One

Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer

(2011) Yasuhiro Nihon-Yanagi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements

(2011) Erez Koren et al.   DRUG DELIVERY

Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia

(2011) R. B. Walter et al.   HAEMATOLOGICA

Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients

(2011) E. Arvaniti et al.   HAEMATOLOGICA

Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells

(2011) Hongyong Zhang et al.   Nanomedicine-Nanotechnology Biology and Medicine

Targeted Drug Delivery by Gemtuzumab Ozogamicin: Mechanism-Based Mathematical Model for Treatment Strategy Improvement and Therapy Individualization

(2011) Eva Jager et al.   PLoS One

Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways

(2010) D. C. Hassane et al.   BLOOD

Targeting neuropilin-1 in human leukemia and lymphoma

(2010) K. Karjalainen et al.   BLOOD

Induction of Cancer Cell Death by Self-assembling Nanostructures Incorporating a Cytotoxic Peptide

(2010) S. M. Standley et al.   CANCER RESEARCH

Mycobacterium tuberculosisLipoproteins Directly Regulate Human Memory CD4+T Cell Activation via Toll-Like Receptors 1 and 2

(2010) Christina L. Lancioni et al.   INFECTION AND IMMUNITY

Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells

(2009) Wenjie Xie et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A phase I/II trial of TLR-7 agonist immunotherapy in chronic lymphocytic leukemia

(2009) D E Spaner et al.   LEUKEMIA

Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor

(2009) Hong-Zhen Yang et al.   PLoS One

Cellular Internalization and Distribution of Arginine-Rich Peptides as a Function of Extracellular Peptide Concentration, Serum, and Plasma Membrane Associated Proteoglycans

(2008) Michie Kosuge et al.   BIOCONJUGATE CHEMISTRY

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

(2008) A. Hagenbeek et al.   BLOOD

TLR2 – promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity

(2008) Ulrich Zähringer et al.   IMMUNOBIOLOGY

Novel approaches for the treatment of NHL: Proteasome inhibition and immune modulation

(2008) Owen A. O'Connor et al.   LEUKEMIA & LYMPHOMA

The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy

(2008) E. L. J. M. Smits et al.   ONCOLOGIST

Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy

(2007) Sébastien Deshayes et al.   ADVANCED DRUG DELIVERY REVIEWS